1-4 of 4
nivolumab
Close
Save search
Sort by
Journal Articles

Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide

Free
Laura K. Schoch, Kenneth R. Cooke, Nina D. Wagner-Johnston, Ivana Gojo, Lode J. Swinnen, Philip Imus, Ephraim J. Fuchs, Mark Levis, Richard F. Ambinder, Richard J. Jones, Douglas E. Gladstone
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2226–2229.
https://doi.org/10.1182/bloodadvances.2018019208
Published: 2018
Journal Articles

Nivolumab-induced cold agglutinin syndrome successfully treated with rituximab

Free
Clinical Trials & Observations
Merve Hasanov, Sergej N. Konoplev, Cristhiam M. Rojas Hernandez
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1865–1868.
https://doi.org/10.1182/bloodadvances.2018019000
Published: 2018
Journal Articles

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Free
Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2643–2654.
https://doi.org/10.1182/bloodadvances.2017012534
Published: 2017
Journal Articles

High-grade neutropenia in a patient successfully treated with nivolumab for refractory primary mediastinal B-cell lymphoma

Free
Clinical Trials & Observations
Zachary Wright, Alexander Brown
Journal: Blood Advances
Blood Adv (2017) 1 (17): 1306–1308.
https://doi.org/10.1182/bloodadvances.2017008607
Published: 2017